Metoclopramide Dosage and Administration for Hiccups
Evidence-Based Dosing Guidelines
- Metoclopramide can be administered at 5-20 mg orally or intravenously for hiccups, as recommended by the American Society of Clinical Oncology 1, 2
- For breakthrough therapy in radiation-induced nausea with hiccups, metoclopramide can be titrated up as needed to a maximum of 3-4 administrations daily, with a strength of evidence supported by the American Society of Clinical Oncology 2, 3
Administration Considerations
- Intravenous administration may be considered for patients unable to take oral medications or requiring rapid relief, according to the American Society of Clinical Oncology 1
Safety Considerations and Adverse Effects
- More serious adverse effects of metoclopramide can include extrapyramidal symptoms and dystonic reactions, as reported by the American Academy of Pediatrics 4, 5
- Repeated doses of metoclopramide can potentially prolong QT interval and precipitate torsades de pointes, with a warning from the American Academy of Pediatrics 4
- Caution is advised in patients with impaired renal or hepatic function, the elderly, and those with CNS depression, as recommended by the American Academy of Pediatrics 5
Special Situations
- For hiccups associated with chemotherapy or radiation therapy, metoclopramide can be used as a breakthrough therapy at 5-20 mg oral or IV, as recommended by the American Society of Clinical Oncology 1, 2
Metoclopramide Dosing for Intractable Hiccups
Route of Administration
- The American Society of Clinical Oncology endorses intravenous administration of metoclopramide at 10-20 mg every 6 hours for hiccups associated with cancer treatment, with a maximum of 3-4 administrations daily, and both oral and intravenous routes demonstrate similar efficacy when gastrointestinal absorption is intact 6
Important Safety Considerations
- The National Comprehensive Cancer Network and American family physician recommend avoiding metoclopramide in patients with pheochromocytoma, seizure disorders, GI bleeding, or GI obstruction, as well as severe renal or hepatic impairment, which requires dose adjustment 7